Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amines. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ruthenium pincer catalyst enables direct amine synthesis from alcohols. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Patent CN101657437A reveals a novel Levocetirizine synthesis route. Discover cost-effective manufacturing and high-purity supply chain solutions for global pharma.
Patent CN115975968B reveals novel amine dehydrogenase mutants for high-purity chiral amines. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112142784B details iridium-catalyzed asymmetric hydrogenation yielding high-purity chiral amines with >99% ee, enabling cost-effective API manufacturing.
Patent CN100427456C reveals hydrogen reduction method. Offers supply chain stability and cost efficiency for agrochemical intermediates manufacturing globally.
Patent CN119614533B reveals thermostable enzyme mutants improving R-chiral amine synthesis efficiency and supply chain stability for pharmaceutical intermediates.
Patent CN110577941B reveals mutated enzymes for high-purity chiral amine synthesis, offering cost reduction in pharmaceutical intermediate manufacturing via biocatalysis.
Patent CN110577941B details mutated amine dehydrogenase for asymmetric reductive amination, offering high optical purity and scalable biocatalysis for pharmaceutical intermediates.
Patent CN109134267B discloses a metal-free route to aromatic amines from alkyl aromatics. Offers significant cost reduction and scalability for API manufacturing.
Discover the metal-free synthesis of aromatic amines via patent CN109134267A. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN116406358A reveals novel spirobifluorene amines enhancing OLED efficiency. Discover supply chain advantages and high-purity manufacturing capabilities.
Patent CN101547890A details a catalytic asymmetric synthesis of primary amines using spiroboronic esters, offering high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN1140496C reveals advanced ruthenium catalyst technology for aromatic amine hydrogenation. Delivers high purity cycloaliphatic amines with significant supply chain and cost advantages for global manufacturers.
Patent CN102229537B reveals a one-pot synthesis for Diphenhydramine Citrate, offering significant cost reduction and streamlined supply chain for API manufacturing.
Patent CN110914417B reveals high-activity transaminase for chiral amine synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN103214455A reveals a mild hypochlorite oxidation route for Bilastine, offering high yield and purity for reliable pharmaceutical intermediate supply chains.
Novel transaminase mutants for chiral amine production. Enhanced stability at 55°C and pH 10. Cost-effective biocatalysis for pharma intermediates.
Patent CN104263803B enables high-purity S-2-tetrahydronaphthalene amines production with superior yield and optical purity for reliable pharmaceutical intermediates supply chains.
Patent CN1553893A details a novel thionylation process for anticancer adjuvants. Offers scalable routes for high-purity pharmaceutical intermediates with reduced toxicity risks.